01535nam0 22002773i 450 SUN011244020171122122146.9230.00feie-l- e-un n-e- sico (3) 1748 (A)SUN 20171122d1748 |0itac50 baitaIT||||||||| |||||||||*Ragioni a favor di D. Antonio Gomes Figueirò odierno appaltator generale della ragion proibitiva del tabacco nel regno di Napoli da esaminarsi nella giunta de' cinque ministri trascelti da S.M. che Dio guardiNapoli, 1748LIII, [3] p. ; 4°Il nome dell' Autore in calce: Carlo FranchiNapoliSUNL000005Franchi, CarloSUNV086663180091ITSOL20181109RICAhttps://books.google.it/books?id=f7WteqIAJ2kC&printsec=frontcover&hl=it#v=onepage&q&f=falseVolume digitalizzato.SUN0112440UFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZA00 ANTICO BL.700.206 d 00 BL 112440 In misc. con altre opere.UFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZABL112440ANTICO BL.700.206 dcaIn misc. con altre opere.Ragioni a favor di D. Antonio Gomes Figueirò odierno appaltator generale della ragion proibitiva del tabacco nel regno di Napoli da esaminarsi nella giunta de' cinque ministri trascelti da S.M. che Dio guardi1522145UNICAMPANIA04724nam 2201177z- 450 991055749550332120210501(CKB)5400000000042876(oapen)https://directory.doabooks.org/handle/20.500.12854/69256(oapen)doab69256(EXLCZ)99540000000004287620202105d2020 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierArteriogenesis and Therapeutic NeovascularizationBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20201 online resource (220 p.)3-03936-593-2 3-03936-594-0 For many years, arteriogenesis, also called collateral formation, has been regarded as being a beneficial process to restore blood flow to distal tissues in occluded arteries. Therefore, it is frequently referred to in relation to therapeutic angiogenesis. Despite the big clinical potential and the many promising clinical trials on arteriogenesis and therapeutic angiogenesis, the exact molecular mechanisms involved in the multifactorial processes of arteriogenesis are still not completely understood. A better understanding is needed in order to define successful clinical therapies. In this Special Issue, multiple aspects of arteriogenesis and therapeutic angiogenesis will be addressed, ranging from the role of inflammatory processes and immune cells, to growth factors, microRNAs and environmental factors like hypoxia. Therapeutic angiogenesis will also be discussed in relation to the atherosclerosis and intraplaque angiogenesis in hypoxic lesions, as well as specific forms of arteriogenesis in relation to spinal cord blood supply and aorta surgery. The effects of exercise, a frequently prescribed therapy for PAD patients, on arteriogenesis are also discussed. Overall, the papers in this Special Issue on arteriogenesis and therapeutic angiogenesis provide important new insights in the underlying pathophysiological mechanism of these complex processes and may be helpful to define a successful future intervention directed at therapeutic angiogenesis.MedicinebicsscA-to-I editingactivity-based benefitsangiogenesisaortic diseasearteriogenesisatherosclerosisblood flow recoveryblood flow restrictioncapillarycollateral artery growthcollateral growthcollateral networkeffect mechanismEgr-1endothelial cellsepitranscriptomeERKfactor VII activating proteasefemoral artery ligationFGFR-1GH and eNOSGHAS trialHABP2hind limb ischemiahyperoxygenationIGF-Iinflammationinnate immunityisomiRsKCa3.1KV1.3lower extremity arterial diseasem6Amacrophagesmast cellmatrigelmicroRNAmicroRNA-212/132n/aneo-vascularizationneovascularizationNONOTCHoxidative stress and arterial inflammationparaplegiaparaspinous compartmentPDFG-Rpericyteperipheral arterial diseasepotassium channelrAAVRNA methylationRNA modificationsSMC proliferationspinal cord ischemiaTAAATLR2/6training effectsvascular biologyvascular homeostasisVEGFvein graft diseaseVHL loss of functionαSM-actinMedicineDeindl Elisabethedt1294156Quax PauledtWaltenberger JohannesedtSchmitz-Rixen ThomasedtDeindl ElisabethothQuax PaulothWaltenberger JohannesothSchmitz-Rixen ThomasothBOOK9910557495503321Arteriogenesis and Therapeutic Neovascularization3022943UNINA